Avadel Pharmaceuticals Stock News

LPL Financial LLC grew its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) by 18.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,150 shares of the companys stock after buying an additional 3,000 shares during the quarter. LPL Financial LLCs holdings in Avadel []

DUBLIN, Ireland, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief E

DUBLIN, Ireland, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in the following upcoming investor conferences:

DUBLIN, Ireland, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief Exe

Analysts expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) to report ($0.42) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Avadel Pharmaceuticals earnings, with estimates ranging from ($0.49) to ($0.26). Avadel Pharmaceuticals posted earnings per share of ($0.24) in the same quarter last year, which indicates a negative year-over-year []

Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q3 2021 Results - Earnings Call Transcript

DUBLIN, Ireland, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that it will host a confer

Avadel Pharmaceuticals: I Am Holding

New York, New York--(Newsfile Corp. - October 18, 2021) -  Pomerantz LLP is investigating claims on behalf of investors of Avadel Pharmaceuticals plc ("Avadel" or the "Company") (NASDAQ: AVDL). Such

A key regulatory decision is overdue, leaving shareholders to wonder when it might arrive.

DUBLIN, Ireland, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that the U.S. Food and Dru

Investors need to pay close attention to Avadel (AVDL) stock based on the movements in the options market lately.

DUBLIN, Ireland, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for

Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2021 Results - Earnings Call Transcript

DUBLIN, Ireland, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for